BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8980158)

  • 1. Effects of four years' treatment with biosynthetic human growth hormone (GH) on body composition in GH-deficient hypopituitary adults.
    Al-Shoumer KA; Page B; Thomas E; Murphy M; Beshyah SA; Johnston DG
    Eur J Endocrinol; 1996 Nov; 135(5):559-67. PubMed ID: 8980158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of measurements of body composition by total body potassium, bioimpedance analysis, and dual-energy X-ray absorptiometry in hypopituitary adults before and during growth hormone treatment.
    Beshyah SA; Freemantle C; Thomas E; Johnston DG
    Am J Clin Nutr; 1995 Jun; 61(6):1186-94. PubMed ID: 7762516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults.
    Beshyah SA; Freemantle C; Thomas E; Rutherford O; Page B; Murphy M; Johnston DG
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):179-89. PubMed ID: 7704962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 7 years of growth hormone replacement therapy in hypopituitary adults.
    Chrisoulidou A; Beshyah SA; Rutherford O; Spinks TJ; Mayet J; Kyd P; Anyaoku V; Haida A; Ariff B; Murphy M; Thomas E; Robinson S; Foale R; Johnston DG
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3762-9. PubMed ID: 11061536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
    Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults.
    Beshyah SA; Freemantle C; Shahi M; Anyaoku V; Merson S; Lynch S; Skinner E; Sharp P; Foale R; Johnston DG
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):73-84. PubMed ID: 7889635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year.
    Fisker S; Vahl N; Hansen TB; Jørgensen JO; Hagen C; Orskov H; Christiansen JS
    Metabolism; 1997 Jul; 46(7):812-7. PubMed ID: 9225837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body composition during GH replacement in adults - methodological variations with respect to gender.
    Koranyi J; Bosaeus I; Alpsten M; Bengtsson BA; Johannsson G
    Eur J Endocrinol; 2006 Apr; 154(4):545-53. PubMed ID: 16556717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body composition analysis by dual energy x-ray absorptiometry and anthropometry in adults with childhood-onset growth hormone (GH) deficiency before and after six months of recombinant GH therapy.
    Sartorio A; Narici M; Conti A; Giambona S; Ortolani S; Faglia G
    J Endocrinol Invest; 1997; 20(7):417-23. PubMed ID: 9309541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adults with partial growth hormone deficiency have an adverse body composition.
    Murray RD; Adams JE; Shalet SM
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1586-91. PubMed ID: 15070916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinuing long-term GH replacement therapy--a randomized, placebo-controlled crossover trial in adult GH deficiency.
    Filipsson Nyström H; Barbosa EJ; Nilsson AG; Norrman LL; Ragnarsson O; Johannsson G
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3185-95. PubMed ID: 22791760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole body and regional soft tissue changes in growth hormone deficient adults after one year of growth hormone treatment: a double-blind, randomized, placebo-controlled study.
    Hansen TB; Vahl N; Jørgensen JO; Christiansen JS; Hagen C
    Clin Endocrinol (Oxf); 1995 Dec; 43(6):689-96. PubMed ID: 8736270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender difference in the response of growth hormone (GH)-deficient adults to GH therapy.
    Hayes FJ; Fiad TM; McKenna TJ
    Metabolism; 1999 Mar; 48(3):308-13. PubMed ID: 10094105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
    Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
    Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.
    Weaver JU; Monson JP; Noonan K; John WG; Edwards A; Evans KA; Cunningham J
    J Clin Endocrinol Metab; 1995 Jan; 80(1):153-9. PubMed ID: 7829604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database.
    Monson JP; Abs R; Bengtsson BA; Bennmarker H; Feldt-Rasmussen U; Hernberg-Stâhl E; Thorén M; Westberg B; Wilton P; Wüster C
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):281-9. PubMed ID: 10971444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of GH replacement on 24-h ambulatory blood pressure and its circadian rhythm in adult GH deficiency.
    Ahmad AM; Hopkins MT; Weston PJ; Fraser WD; Vora JP
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):431-7. PubMed ID: 11966735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) substitution for one year normalizes elevated GH-binding protein levels in GH-deficient adults secondary to a reduction in body fat. A placebo-controlled trial.
    Fisker S; Vahl N; Hansen TB; Jørgensen JO; Hagen C; Orskov H; Christiansen JS
    Growth Horm IGF Res; 1998 Apr; 8(2):105-12. PubMed ID: 10987677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone binding protein correlates strongly with leptin and percentage body fat in GH-deficient adults, is increased by GH replacement but does not predict IGF-I response.
    Florkowski CM; Barnard R; Livesey JH; Veveris T; Espiner EA; Donald RA
    Growth Horm IGF Res; 1999 Feb; 9(1):35-40. PubMed ID: 10207506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.